Effects of vitamin D receptor gene polymorphisms on low-resistance training using exercise machines: The 'power rehabilitation' program

International Journal of Molecular Medicine

Volumn 23, Issue 1, 2009, Pages 81-88

  Murakami, Shin Ichiro ^b   Otsuki, Takemi ^a   Maeda, Megumi ^a   Miura, Yoshie ^a   Morii, Seiko ^b   Kiyokane, Kenji ^b   Hayakawa, Shin Ichi ^b   Maeda, Atsushi ^b   Imakawa, Takayo ^b   Harada, Shunpei ^b   Handa, Torataro ^b   Nishimura, Yasumitsu ^a   Murakami, Shuko ^a   Kumagai, Naoko ^a   Hayashi, Hiroaki ^a   Chen, Ying ^a   Suemori, Shin Ichiro ^a   Fukushima, Yumiko ^b   Nishida, Seikoh ^b   Fukushima, Keisuke ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Fukushima Rehabilitation College   (Japan)

Author keywords

Low resistance training; Rehabilitation; Single nucleotide polymorphism; Vitmin D receptor

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

AGED; ARTICLE; DAILY LIFE ACTIVITY; ELDERLY CARE; FEMALE; GENETIC ASSOCIATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; MALE; MEDICAL INSTRUMENTATION; MUSCLE STRENGTH; MUSCLE TRAINING; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REHABILITATION CARE; SINGLE NUCLEOTIDE POLYMORPHISM; AGE; GENETICS; REHABILITATION; RESISTANCE TRAINING;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGED, 80 AND OVER; CILIARY NEUROTROPHIC FACTOR; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY OF LIFE; RECEPTORS, CALCITRIOL; REHABILITATION; RESISTANCE TRAINING;

EID: 61749097273     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000104     Document Type: Article

References (33)

1. Department of State and the Department of Health and Human Services, National Institute on Aging, National Institutes of Health, Washington, DC, USA: Why population aging matters: A global perspective. March 13, 2007, http://www.state.gov/g/oes/rls/or/81537.htm.
2. WHO: Health topics ageing. http://www.who.int/topics/ageing/en/.
3. Ministry of Internal Affairs and Communications, Statistics Bureau, Director-General for Policy Planning (Statistical Standards) and Statistical Research and Training Institute, Japan: http://www.stat.go.jp/english/data/handbook/c02cont.htm.
4. Special report: Japan's Aging population: A challenge for its economy and society, AsiaSource: AsiaToday - A resource of the Asia Society, October 7, 2003, http://www.asiasource.org/news/ at∓_02.cfm?newsid=102450.
5. BBC News: Asia-Pacific, fears over Japan's ageing population, December, 22, 2000, http://news.bbc.co.uk/2/hi/asia-pacific/1083097.htm.
6. Ohnabe H: Current trends in rehabilitation engineering in Japan. Assist Technol 18: 220-232, 2006.
7. Miyawaki K, Iwami T, Obinata G, Shimada Y, Matsunaga T and Sato M: Development of FES-rowing machine. Conf Proc IEEE Eng Med Biol Soc 2007: 2768-2771, 2007.
8. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M and Dobnig H: Vascular calcification and osteoporosis - from clinical observation towards molecular understanding. Osteoporos Int 18: 251-259, 2007.
9. Otsuki T, Sakaguchi H, Hatta E, et al: Effects of genetic and nutritional factors on bone mineral density in young adults. Int J Mol Med 14: 669-676, 2004.
10. Grundberg E, Brändström H, Ribom EL, Ljunggren O, Mallmin H and Kindmark A: Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol 150: 323-328, 2004.
11. Langdahl BL, Gravholt CH, Brixen K and Eriksen EF: Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fractures. Eur J Clin Invest 30: 608-617, 2000.
12. De Brito Júnior RB, Scarel-Caminaga RM, Trevilatto PC, de Souza AP and Barros SP: Polymorphisms in the vitamin D receptor gene are associated with periodontal disease. J Periodontol 75: 1090-1095, 2004.
13. Naito M, Miyaki K, Naito T, et al: Association between vitamin D receptor gene haplotypes and chronic periodontitis among Japanese men. Int J Med Sci 4: 216-222, 2007.
14. Arking DE, Fallin DM, Fried LP, et al: Variation in the ciliary neurotrophic factor gene and muscle strength in older Caucasian women. J Am Geriatr Soc 54: 823-826, 2006.
15. Van Rossum EF and Lamberts SW: Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59: 333-357, 2004.
16. Walston J, Arking DE, Fallin D, et al: IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol 40: 344-352, 2005.
17. Wade DT and Collin C: The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud 10: 64-67, 1988.
18. Blum L and Korner-Bitensky N: Usefulness of the Berg balance scale in stroke rehabilitation: a systematic review. Phys Ther 88: 559-566, 2008.
19. Sainsbury A, Seebass G, Bansal A and Young JB: Reliability of the Barthel index when used with older people. Age Ageing 34: 228-232, 2005.
20. Mathias S, Nayak US and Isaacs B: Balance in elderly patients: the 'get-up and go' test. Arch Phys Med Rehabil 67: 387-389, 1986.
21. Christofoletti G, Oliani MM, Gobbi S, Stella F, Bucken Gobbi LT and Renato Canineu P: A controlled clinical trial on the effects of motor intervention on balance and cognition in institutionalized elderly patients with dementia. Clin Rehabil 22: 618-626, 2008.
22. Nordin E, Lindelof N, Rosendahl E, Jensen J and Lundin-Olsson L: Prognostic validity of the timed up-and-go test, a modified get-up and-go test, staff's global judgement and fall history in evaluating fall risk in residential care facilities. Age Ageing 37: 442-448, 2008.
23. Otsuki T, Ichihara K, Tomokuni A, et al: Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis. Int J Mol Med 4: 407-411, 1999.
24. + regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol 19: 357-368, 2006.
25. Tomita N and Oto M: Molecular genetic diagnosis of familial tumors. Int J Clin Oncol 9: 246-256, 2004.
26. Erichsen HC and Chanock SJ: SNPs in cancer research and treatment. Br J Cancer 90: 747-751, 2004.
27. Nordfors L, Lindholm B and Stenvinkel P: End-stage renal disease - not an equal opportunity disease: the role of genetic polymorphisms. J Intern Med 258: 1-12, 2005.
28. Corella D and Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 25: 341-390, 2005.
29. Rao M, Wong C, Kanetsky P, et al: Cytokine gene polymorphism and progression of renal and cardiovascular diseases. Kidney Int 72: 549-556, 2007.
30. Polgar O, Robey RW and Bates SE: ABCG2: structure, function and role in drug response. Expert Opin Drug Metab Toxicol 4: 1-15, 2008.
31. Ueno H, Kiyosawa K and Kaniwa N: Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Br J Cancer 97: 145-151, 2007.
32. Abraham J, Earl HM, Pharoah PD and Caldas C: Pharmacogenetics of cancer chemotherapy. Biochim Biophys Acta 1766: 168-183, 2006.
33. Cantor CR: The use of genetic SNPs as new diagnostic markers in preventive medicine. Ann NY Acad Sci 1055: 48-57, 2005.